Dan Maarten Berger

This inventor holds 16 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent, primarily in Protein Kinase Inhibitors. Top assignees: Wyeth, American Cyanamid Company, Wyeth Holdings Corporation. Active years: 1995-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dan Maarten Berger. Retrieved from https://idiyas.com/inventor/dan-maarten-berger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 1)

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 5.6

ph-index = 9

Forward Citations = 361(Granted Patents)

Location History:

Orangeburg, NY (US) (1995 - 1997)
New City, NY (US) (2001 - 2013)

Company Filing History:

American Cyanamid Company

patents

2 out of 113

Wyeth Holdings Corporation

patents

4. 1 out of 118

Osi Pharmaceuticals, Inc.

patents

5. 1 out of 834,659

Other

patents

Years Active: 1995-2013

Loading Chart...

Areas of Expertise:

Aminofuropyridine Derivatives

Substituted Quinoline

Protein Kinase Inhibitors

Quinolinecarbonitrile

Tricyclic Compounds

MDR Reversal Agents

Regioselective Preparation

Naphthyridines

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8378104 - 7-aminofuropyridine derivatives (2013-02-19),

2. RE42376 - Substituted 3-cyanoquinolines (2011-05-16),

3. 7767671 - 3-Quinolinecarbonitrile protein kinase inhibitors (2010-08-03),

4. 7449460 - 3-Quinolinecarbonitrile protein kinase inhibitors (2008-11-11),

5. 7365197 - Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines (2008-04-29),

6. 7105531 - Tricyclic protein kinase inhibitors (2006-09-12),

7. 6780996 - Process for the preparation of 7-substituted-3 quinolinecarbonitriles (2004-08-24),

8. 6689772 - 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors (2004-02-10),

9. 6638929 - Tricyclic protein kinase inhibitors (2003-10-28),

10. 6521618 - 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors (2003-02-18),

11. 6297258 - Substituted 3-cyanoquinolines (2001-10-02),

12. 6288082 - Substituted 3-cyanoquinolines (2001-09-11),

13. 5639887 - MDR reversal agents (1997-06-17),

14. 5561141 - MDR reversal agents (1996-10-01),

15. 5550149 - MDR reversal agents (1996-08-27),

Title: Dan Maarten Berger - Innovative Inventor from New City, NY

Introduction: Dan Maarten Berger is a prolific inventor hailing from New City, NY, known for his groundbreaking contributions to various fields.

Latest Patents: Dan Maarten Berger holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Dan Maarten Berger has worked with top research institutions and companies, leading projects that have resulted in cutting-edge inventions and technological advancements.

Collaborations: Throughout his career, Dan Maarten Berger has collaborated with renowned inventors, patent attorneys, and research institutions, fostering a culture of innovation and creativity in his projects.

Conclusion: Dan Maarten Berger's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the industry, with his work continuing to inspire future generations of inventors.

Profile summary based on public USPTO records.